Axactor (ACR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Nov, 2025Executive summary
Collection performance reached 101% in Q1 2025, supporting updated forecasts and reflecting strong operational execution.
Gross revenue was EUR 77.4 million, up 7% year-over-year when adjusted for the Spanish portfolio sale, despite a seasonally slow quarter.
EBITDA increased 23% year-over-year to over EUR 32 million, with a 50% margin driven by cost reductions and margin expansion.
Annualized return on equity hit 12%, an all-time high and aligned with 2026 targets.
Significant growth in the 3PC segment, with 28% revenue increase and margin expansion across all active countries.
Financial highlights
Gross revenue for Q1 was EUR 77.4 million, down 2% year-over-year, but up 7% excluding the Spanish portfolio sale.
NPL segment gross revenue was EUR 62 million; 3PC segment revenue was EUR 15.2 million, up 28% year-over-year.
Group total revenue was EUR 65 million, up 15% year-over-year.
Net profit after tax was EUR 10.1 million, up from EUR 0.7 million year-over-year; EPS at EUR 0.033.
Cash EBITDA was EUR 46.7 million, down 5% year-over-year, mainly due to the portfolio divestment.
Outlook and guidance
Collection performance is expected to remain around 100% going forward.
3PC segment is projected to continue substantial growth with healthy margins, supported by a strong pipeline and recent contract wins.
Full IT cost savings expected from Q3, reducing OpEx by EUR 700,000 per quarter.
NPL investments guided at EUR 100–200 million for 2024–2026, with activity expected to pick up later in the year.
Deleveraging strategy continues, with plans to refinance or repay 2026 bond maturity during 2025.
Latest events from Axactor
- Major equity raise and NPL revaluation drive net loss, but leverage and 3PC growth improve.ACR
Q2 2026 - Cost optimization, tech adoption, and strong growth drive efficiency and profitability.ACR
Status update - Major equity and bond deals cut funding costs and set new growth targets amid revenue decline.ACR
Q1 2026 - EUR 200m placement and co-investment deal to drive growth, boost capacity, and reduce leverage.ACR
Investor update - Revenue and margins improved, with strong 3PC growth and focus on deleveraging over dividends.ACR
Q4 2025 - Refinancing, strong collections, and 3PC growth support a positive outlook.ACR
Q2 2025 - Cash EBITDA up 6% to EUR 59M, but net profit and ROE to shareholders fell to 0%.ACR
Q3 2024 - Cash EBITDA up 3% to EUR 61.1M as cost control offsets 2% revenue decline.ACR
Q2 2024 - Q4 revenue surged on a Spanish sale, but negative revaluations led to a net loss; liquidity is strong.ACR
Q4 2024